L 01 FB – Inhibitory CD22 L 01 FB 01 – inotuzumab ozogamycyny L 01 FB 02 – moksetumomab pasudotoksu
L 01 FC – Inhibitory CD38 L 01 FC 01 – daratumumab L 01 FC 02 – izatuksymab
L 01 FD – Inhibitory HER2 L 01 FD 01 – trastuzumab L 01 FD 02 – pertuzumab L 01 FD 03 – trastuzumab emtanzyny L 01 FD 04 – trastuzumab derukstekanu L 01 FD 05 – trastuzumab duokarmazyny L 01 FD 06 – margetuksimab L 01 FD 07 – zanidatamab
L 01 FE – Inhibitory EGFR L 01 FE 01 – cetuksymab L 01 FE 02 – panitumumab L 01 FE 03 – necitumumab
L 01 FF – Inhibitory PD–1/PD–L1 L 01 FF 01 – niwolumab L 01 FF 02 – pembrolizumab L 01 FF 03 – durwalumab L 01 FF 04 – awelumab L 01 FF 05 – atezolizumab L 01 FF 06 – cemiplimab L 01 FF 07 – dostarlimab L 01 FF 08 – prolgolimab L 01 FF 09 – tyslelizumab L 01 FF 10 – retyfanlibab L 01 FF 11 – sugemalibab L 01 FF 12 – serplulibab L 01 FF 13 – toripalimab L 01 FF 14 – kamrelizumab L 01 FF 15 – enwafolimab L 01 FF 16 – sasanlimab
L 01 FG – Inhibitory VEGF/VEGFR L 01 FG 01 – bewacyzumab L 01 FG 02 – ramucirumab